Original Article

You have full text access to this OnlineOpen article

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C

  1. Hisayuki Hamada M.D.1,2,
  2. Hiroshi Yatsuhashi M.D.1,†,*,
  3. Koji Yano M.D.1,
  4. Manabu Daikoku M.D.1,
  5. Kokichi Arisawa M.D.3,
  6. Osami Inoue M.D.1,
  7. Michiaki Koga M.D.1,
  8. Keisuke Nakata M.D.2,
  9. Katsumi Eguchi M.D.2,
  10. Michitami Yano M.D.1

Article first published online: 11 JUL 2002

DOI: 10.1002/cncr.10662

Issue

Cancer

Cancer

Volume 95, Issue 2, pages 331–339, 15 July 2002

Additional Information

How to Cite

Hamada, H., Yatsuhashi, H., Yano, K., Daikoku, M., Arisawa, K., Inoue, O., Koga, M., Nakata, K., Eguchi, K. and Yano, M. (2002), Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer, 95: 331–339. doi: 10.1002/cncr.10662

Author Information

  1. 1

    Institute for Clinical Research, World Health Organization Collaborating Center for Reference and Research on Viral Hepatitis, National Nagasaki Medical Center, Nagasaki, Japan

  2. 2

    The First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan

  3. 3

    Department of Preventive Medicine and Health Promotion, Nagasaki University School of Medicine, Nagasaki, Japan

  1. †

    Fax: (011) +81-957-53-6675

*Institute for Clinical Research, World Health Organization Collaborating Center for Reference and Research on Viral Hepatitis, National Nagasaki Medical Center, Kubara 2-1001-1, Omura 852-8562, Nagasaki, Japan

Publication History

  1. Issue published online: 11 JUL 2002
  2. Article first published online: 11 JUL 2002
  3. Manuscript Accepted: 19 FEB 2002
  4. Manuscript Revised: 11 FEB 2002
  5. Manuscript Received: 15 OCT 2001

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (104K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hiroki Nishikawa, Eriko Iguchi, Yorimitsu Koshikawa, Soichiro Ako, Tadashi Inuzuka, Haruhiko Takeda, Jun Nakajima, Fumihiro Matsuda, Azusa Sakamoto, Sinichiro Henmi, Keiichi Hatamaru, Tetsuro Ishikawa, Sumio Saito, Ryuichi Kita, Toru Kimura, Yukio Osaki, The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients, BMC Research Notes, 2012, 5, 1, 135

    CrossRef

  2. 2
    Sumio Watanabe, Nobuyuki Enomoto, Kazuhiko Koike, Namiki Izumi, Hajime Takikawa, Etsuko Hashimoto, Fuminori Moriyasu, Hiromitsu Kumada, Michio Imawari, Cancer preventive effect of pegylated interferon α-2b plus ribavirin in a real-life clinical setting in Japan: PERFECT interim analysis, Hepatology Research, 2011, 41, 10
    Direct Link:
  3. 3
    Chung-Feng Huang, Wan-Long Chuang, Ming-Lung Yu, Chronic hepatitis C infection in the elderly, The Kaohsiung Journal of Medical Sciences, 2011,

    CrossRef

  4. 4
    Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, Kiyoshi Mochizuki, Masahide Oshita, Hideki Hagiwara, Eiji Mita, Toshifumi Ito, Hiroyuki Fukui, Yoshiaki Inui, Taizo Hijioka, Masami Inada, Kazuhiro Kaytayama, Shinji Tamura, Harumasa Yoshihara, Atsuo Inoue, Yasuharu Imai, Michio Kato, Takuya Miyagi, Yuichi Yoshida, Tomohide Tatsumi, Shinichi Kiso, Tatsuya Kanto, Akinori Kasahara, Tetsuo Takehara, Norio Hayashi, Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy, Journal of Hepatology, 2011, 54, 4, 604

    CrossRef

  5. 5
    Yasuhiro Asahina, Kaoru Tsuchiya, Nobuharu Tamaki, Itsuko Hirayama, Tomohiro Tanaka, Mitsuaki Sato, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Teiji Kuzuya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi, Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection, Hepatology, 2010, 52, 2
    Direct Link:
  6. 6
    Hirofumi Uto, Sherri O. Stuver, Katsuhiro Hayashi, Kotaro Kumagai, Fumisato Sasaki, Shuji Kanmura, Masatsugu Numata, Akihiro Moriuchi, Susumu Hasegawa, Makoto Oketani, Akio Ido, Kazunori Kusumoto, Satoru Hasuike, Kenji Nagata, Michinori Kohara, Hirohito Tsubouchi, Increased rate of death related to presence of viremia among hepatitis C virus antibody–positive subjects in a community-based cohort study, Hepatology, 2009, 50, 2
    Direct Link:
  7. 7
    H.-H. Thein, Q. Yi, E. J. Heathcote, M. D. Krahn, Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort, Journal of Viral Hepatitis, 2009, 16, 11
    Direct Link:
  8. 8
    K. Tanaka, I. Tsuji, K. Wakai, C. Nagata, T. Mizoue, M. Inoue, S. Tsugane, Alcohol Drinking and Liver Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence among the Japanese Population, Japanese Journal of Clinical Oncology, 2008, 38, 12, 816

    CrossRef

  9. 9
    Daiki Miki, Hiroshi Aikata, Kiminori Uka, Hiromi Saneto, Tomokazu Kawaoka, Takahiro Azakami, Shintaro Takaki, Soo Cheol Jeong, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi, Toshiyuki Itamoto, Toshimasa Asahara, Koji Arihiro, Kazuaki Chayama, Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma, Journal of Gastroenterology, 2008, 43, 7, 550

    CrossRef

  10. 10
    Hiromi Saneto, Masahiro Kobayashi, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients, Journal of Gastroenterology, 2008, 43, 12, 975

    CrossRef

  11. 11
    Hla-Hla Thein, Qilong Yi, Gregory J. Dore, Murray D. Krahn, Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression, Hepatology, 2008, 48, 2
    Direct Link:
  12. 12
    Soo Ryang Kim, Susumu Imoto, Shuichi Fuki, Ke Ih Kim, Miyuki Taniguchi, Motoko Nagano, Hak Hotta, Ikuo Shouji, Yoshihiro Kanbara, Yoko Maekawa, Masatoshi Kudo, Yoshitake Hayashi, Pegylated interferon α-2b/ribavirin combination therapy for elderly patients with chronic hepatitis C with high viral load of HCV genotype 1b, Kanzo, 2008, 49, 4, 145

    CrossRef

  13. 13
    Gotaro Yamada, Shiro Iino, Tadao Okuno, Masao Omata, Kendo Kiyosawa, Hiromitsu Kumada, Norio Hayashi, Takahiro Sakai, Virological Response in Patients with??Hepatitis C Virus Genotype 1b and??a??High Viral Load, Clinical Drug Investigation, 2008, 28, 1, 9

    CrossRef

  14. 14
    Hideyuki Nomura, Yoichiro Kashiwagi, Ryouko Hirano, Hironori Tanimoto, Nobuo Tsutsumi, Masashi Higashi, Hiromi Ishibashi, Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study, Hepatology Research, 2007, 37, 7
    Direct Link:
  15. 15
    Soo R. Kim, Is long-term interferon monotherapy welcome news for older patients with chronic hepatitis C genotype 1?, Hepatology Research, 2007, 37, 7
    Direct Link:
  16. 16
    Tsugiko Oze, Naoki Hiramatsu, Nao Kurashige, Natsuko Tsuda, Takayuki Yakushijin, Tatsuya Kanto, Tetsuo Takehara, Akinori Kasahara, Michio Kato, Harumasa Yoshihara, Kazuhiro Katayama, Shinji Kubota, Taizo Hijioka, Kazunobu Ishibashi, Masahide Oshita, Hideki Hagiwara, Yoshimichi Haruna, Eiji Mita, Shinji Tamura, Norio Hayashi, Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C, Journal of Gastroenterology, 2006, 41, 9, 862

    CrossRef

  17. 17
    Hiroshi Yoshizawa, Junko Tanaka, Yuzo Miyakawa, National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population, Intervirology, 2006, 49, 1-2, 7

    CrossRef

  18. 18
    Masashi Mizokami, Yasuhito Tanaka, Yuzo Miyakawa, Spread Times of Hepatitis C Virus Estimated by the Molecular Clock Differ among Japan, the United States and Egypt in Reflection of Their Distinct Socioeconomic Backgrounds, Intervirology, 2006, 49, 1-2, 28

    CrossRef

  19. 19
    J. S. Markowitz, E. M. Gutterman, D. Hodes, W. Klaskala, Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C, Journal of Viral Hepatitis, 2005, 12, 2
    Direct Link:
  20. 20
    Lenhard K Rudolph, Hans L Tillmann, Hepatitis C virus infection in the elderly, Aging Health, 2005, 1, 3, 409

    CrossRef

  21. 21
    Hiroshi Kamitsukasa, Hideharu Harada, Hideo Tanaka, Michiyasu Yagura, Hajime Tokita, Akira Ohbayashi, Late liver-related mortality from complications of transfusion-acquired hepatitis C, Hepatology, 2005, 41, 4
    Direct Link:
  22. 22
    Anne M. Larson, The epidemiology of hepatocellular carcinoma in hcv, Current Hepatitis Reports, 2005, 4, 4, 145

    CrossRef

  23. 23
    Jung-Fa Tsai, Jen-Eing Jeng, Lee-Yea Chuang, Mei-Shang Ho, Ying-Chin Ko, Zu-Yau Lin, Min-Yuh Hsieh, Shin-Chern Chen, Wan-Lung Chuang, Liang-Yen Wang, Ming-Lung Yu, Chia-Yen Dai, Habitual Betel Quid Chewing and Risk for Hepatocellular Carcinoma Complicating Cirrhosis, Medicine, 2004, 83, 3, 176

    CrossRef

  24. 24
    Brian L. Pearlman, Hepatitis C Infection: A Clinical Review, Southern Medical Journal, 2004, 97, 4, 365

    CrossRef

  25. 25
    Kendo Kiyosawa, Takeji Umemura, Tetsuya Ichijo, Akihiro Matsumoto, Kaname Yoshizawa, Amal Gad, Eiji Tanaka, Hepatocellular carcinoma: Recent trends in Japan, Gastroenterology, 2004, 127, 5, S17

    CrossRef

  26. 26
    David E Kaplan, K.Rajender Reddy, Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes, Clinics in Liver Disease, 2003, 7, 3, 683

    CrossRef

View Full Article (HTML) Get PDF (104K)